Does TEMOZOLOMIDE Cause Interstitial lung disease? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.1% of all adverse event reports for TEMOZOLOMIDE.
15
Reports of Interstitial lung disease with TEMOZOLOMIDE
0.1%
of all TEMOZOLOMIDE reports
6
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From TEMOZOLOMIDE?
Of the 15 reports, 6 (40.0%) resulted in death, 8 (53.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TEMOZOLOMIDE Cause?
Disease progression (1,562)
Death (1,403)
Off label use (1,357)
Product use in unapproved indication (1,353)
Thrombocytopenia (1,300)
Drug ineffective (1,131)
Nausea (1,071)
Neutropenia (809)
Malignant neoplasm progression (779)
Fatigue (766)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TEMOZOLOMIDE Alternatives Have Lower Interstitial lung disease Risk?
TEMOZOLOMIDE vs TEMSIROLIMUS
TEMOZOLOMIDE vs TENAMFETAMINE
TEMOZOLOMIDE vs TENAPANOR
TEMOZOLOMIDE vs TENECTEPLASE
TEMOZOLOMIDE vs TENELIGLIPTIN